[go: up one dir, main page]

HU0004543D0 - - Google Patents

Info

Publication number
HU0004543D0
HU0004543D0 HU0004543A HUP0004543A HU0004543D0 HU 0004543 D0 HU0004543 D0 HU 0004543D0 HU 0004543 A HU0004543 A HU 0004543A HU P0004543 A HUP0004543 A HU P0004543A HU 0004543 D0 HU0004543 D0 HU 0004543D0
Authority
HU
Hungary
Prior art keywords
alkyl
aryl
cyclopropylhydrocarbylamino
heteroarylene
alkoxy
Prior art date
Application number
HU0004543A
Other languages
English (en)
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of HU0004543D0 publication Critical patent/HU0004543D0/hu
Publication of HUP0004543A2 publication Critical patent/HUP0004543A2/hu
Publication of HUP0004543A3 publication Critical patent/HUP0004543A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
HU0004543A 1999-11-17 2000-11-16 Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them HUP0004543A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914434A FR2801051B1 (fr) 1999-11-17 1999-11-17 Nouveaux composes aminopyrroline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
HU0004543D0 true HU0004543D0 (hu) 2001-02-28
HUP0004543A2 HUP0004543A2 (hu) 2001-10-28
HUP0004543A3 HUP0004543A3 (en) 2001-11-28

Family

ID=9552203

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004543A HUP0004543A3 (en) 1999-11-17 2000-11-16 Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US6300366B1 (hu)
EP (1) EP1101756B1 (hu)
JP (1) JP3274456B2 (hu)
KR (1) KR100453981B1 (hu)
CN (1) CN1158257C (hu)
AT (1) ATE234815T1 (hu)
AU (1) AU771745B2 (hu)
BR (1) BR0005442A (hu)
CA (1) CA2325781C (hu)
DE (1) DE60001706T2 (hu)
DK (1) DK1101756T3 (hu)
EA (1) EA004042B1 (hu)
ES (1) ES2194691T3 (hu)
FR (1) FR2801051B1 (hu)
HK (1) HK1036454A1 (hu)
HU (1) HUP0004543A3 (hu)
MX (1) MXPA00011239A (hu)
NO (1) NO317987B1 (hu)
NZ (1) NZ508228A (hu)
PL (1) PL343920A1 (hu)
PT (1) PT1101756E (hu)
SI (1) SI1101756T1 (hu)
ZA (1) ZA200006731B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL372695A1 (en) 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
GB0521083D0 (en) * 2005-10-17 2005-11-23 Novartis Ag Organic compounds
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
GB201318886D0 (en) * 2013-10-25 2013-12-11 Givaudan Sa Improvements i or relating to organic compounds
CN114716359B (zh) * 2022-04-28 2023-01-17 广东医科大学 一种氢化吲哚亚胺非对映异构体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2029297A1 (de) * 1970-06-13 1971-12-30 Farbenfabriken Bayer Ag, 5090 Leverkusen Neue Aminophenyl-cycloamidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US3887569A (en) * 1970-10-30 1975-06-03 Mcneilab Inc 2-Imino-piperidines
NL7412695A (nl) * 1974-09-26 1976-03-30 Stamicarbon De bereiding van een 2-amino-pyrrolinederivaat.
US4579951A (en) * 1984-03-19 1986-04-01 G. D. Searle & Co. Substituted (azacycloalk-2-yl)iminophenols and esters thereof
DE4425070A1 (de) * 1994-07-15 1996-01-18 Degussa Verfahren zur Herstellung optisch aktiver l-substituierter 2-(Aminomethyl)pyrrolidine

Also Published As

Publication number Publication date
AU771745B2 (en) 2004-04-01
JP2001139545A (ja) 2001-05-22
EP1101756B1 (fr) 2003-03-19
EA200001077A2 (ru) 2001-06-25
NZ508228A (en) 2001-03-30
BR0005442A (pt) 2001-07-03
AU7168000A (en) 2001-05-24
ZA200006731B (en) 2001-05-30
PL343920A1 (en) 2001-05-21
CN1298872A (zh) 2001-06-13
JP3274456B2 (ja) 2002-04-15
CA2325781A1 (fr) 2001-05-17
US6300366B1 (en) 2001-10-09
EA200001077A3 (ru) 2001-08-27
NO20005797L (no) 2001-05-18
DE60001706T2 (de) 2004-02-05
SI1101756T1 (en) 2003-06-30
HUP0004543A3 (en) 2001-11-28
KR20010051776A (ko) 2001-06-25
ATE234815T1 (de) 2003-04-15
CA2325781C (fr) 2006-07-18
EA004042B1 (ru) 2003-12-25
EP1101756A1 (fr) 2001-05-23
ES2194691T3 (es) 2003-12-01
MXPA00011239A (es) 2002-05-23
PT1101756E (pt) 2003-06-30
HUP0004543A2 (hu) 2001-10-28
NO317987B1 (no) 2005-01-17
CN1158257C (zh) 2004-07-21
NO20005797D0 (no) 2000-11-16
DK1101756T3 (da) 2003-07-14
KR100453981B1 (ko) 2004-10-20
HK1036454A1 (en) 2002-01-04
DE60001706D1 (de) 2003-04-24
FR2801051B1 (fr) 2001-12-14
FR2801051A1 (fr) 2001-05-18

Similar Documents

Publication Publication Date Title
HK1051850A1 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HU0004543D0 (hu)
ZA200401996B (en) 1-Glyoxylamide indolizines for treating cancer.
DK1103554T5 (da) Dihydrofuro-[3,4-b]quinolein-1-onderivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, som indeholder dem
BG106937A (en) Novel indole derivatives
TW200510309A (en) Chemical compounds
HU9802645D0 (en) New metalloproteinase inhibitors, process for producing them, and pharmaceutical compositions containing them
BG106048A (en) 6-[[(aryl and heteroaryl)oxy]methyl]naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
UA72934C2 (uk) Феніл- і піридилтетрагідропіридини, що інгібують фактор некрозу пухлин, спосіб їх одержання та фармацевтична композиція
DK0841337T3 (da) Substituerede 7,12-dioxabenzo[a]anthracenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, der indeholder disse derivater
DK48188A (da) Ergolinyl-heterocycliske forbindelser og fremgangsmaade til fremstilling deraf
PL334624A1 (en) Novel compounds of 8h-thiene-/2,3-b/pyrolysin-8-one, method of obtaining them and pharmaceutic compositions containing such compounds
HUP0103518A2 (hu) Új 2,3,3a,4,9,9a-hexahidro-8-hidroxi-1H-benz[f]indol-származékok, eljárás előállításukra és alkalmazásuk gyógyszerkészítmények előállítására